article
Charantin: An important lead compound from Momordica charantia for the treatment of diabetes
Journal of Pharmacognosy and Phytochemistry · 2015 · Vol. 3(6) · pp. 163–166
Abstract
The development of effective and safe anti-diabetic agent is still a major challenge for modern scientific research. Traditionally fruit juice of Momordica charantia has been used for treatment of diabetes for centuries. Charantin, a natural steroidal glycoside present in the fruits of this medicinal plant, has been reported to possess potential hypoglycemic activity. However, this phytoconstituent has not been explored yet clinically to treat diabetes. This review summarizes the chemistry, biological activity and reported analytical methods for charantin, a bioactive compound present in M. charantia.
Natural Antidiabetic Agents StudiesAdvances in Cucurbitaceae ResearchTransgenic Plants and ApplicationsMomordicaTraditional medicineDiabetes mellitusMedicineLead compoundChemistryPharmacologyBiochemistryEndocrinology
Citations
45
FWCI
1.34
field-weighted impact
References
0
Percentile
83%
vs. same field & year
Citations per year
Related articles
Pharmacological actions and potential uses of Momordica charantia: a review
Journal of Ethnopharmacology · 2004 · 804 citations
Role of Bitter gourd (Momordica charantia L.) in human health strengthening and regulate different diseases
Journal of Pharmacognosy and Phytochemistry · 2020 · 1 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
